Tamsulosin is an Î±1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH).
Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, including Boehringer-Ingelheim and CSL.
Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra, Contiflo XL, and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such as Canada.
The U.S. patent for Flomax expired in October 2009. The U.S. Food and Drug Administration (FDA) approved generic Flomax in March 2010.
Tamsulosin HCL 0.4
Tamsulosin HCL 0.4 mg Capsule
Note* : DMF Available